首页> 外文OA文献 >Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT

【2h】

Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT

机译：在牛皮癣中的三相3阶段试验的开放标签延伸臂中的剂量调整模式：Cimpasi-1，Cimpasi-2和Cimpact

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A Blauvelt; AB Gottlieb; F Fierens; F Brock; S Wiegratz; H Sofen;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48?weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2) [J] . Alice B. Gottlieb, Andrew Blauvelt, Diamant Tha?i, Journal of the American Academy of Dermatology . 2018,第2期

机译：Certolizumab Pegol用于治疗慢性斑块牛皮癣：结果通过2阶段3，多中心，随机，双盲，安慰剂对照研究（Cimpasi-1和Cimpasi-2）
2. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48?weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT) [J] . Mark Lebwohl, Andrew Blauvelt, Carle Paul, Journal of the American Academy of Dermatology . 2018,第2期

机译：Certolizumab Pegol用于治疗慢性斑块牛皮癣：结果通过48个？几周的阶段3，多中心，随机，双盲，依那西 - 和安慰剂对照研究（Cimpact）
3. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab￠ certolizumab pegol: Results of a phase II randomized, placebo-controlled trial with a re-treatment extension [J] . ReichK., OrtonneJ.-P., GottliebA.B., British Journal of Dermatology . 2012,第1期

机译：聚乙二醇化Fab ￠ certolizumab聚乙二醇成功治疗中度至重度斑块状牛皮癣：II期随机，安慰剂对照试验的结果，延长了治疗时间
4. Pharmacokinetics and Tolerability of Sublingual Fentanyl in Healthy Japanese and Caucasian Volunteers: Phase I, Open-Label Single-Dose Study [C] . U. Lorch, F. Farrell, J. Kilborn, International Pain Clinic Congress . 2008

机译：健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性：I期，开放标签单剂量研究
5. Extended report: Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension [O] . Edward Keystone, Robert Landewé, Ronald van Vollenhoven, -1

机译：扩展报告：certolizumab聚乙二醇单药与甲氨蝶呤联合治疗类风湿性关节炎的长期安全性和有效性：RAPID 1试验和开放标签扩展的5年结果
6. Durability of DLQI Improvements Among Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2) [O] . A Blauvelt, RB Warren, K Reich, 2020

机译：中度至重度斑块牛皮癣患者的DLQI改善的耐久性：三阶段3次试验的三年结果（Cimpasi-1和Cimpasi-2）

Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT

著录项

引文网络

相似文献

相关主题

期刊订阅